Innoviva
FDA approves Innoviva’s Xacduro for intravenous use
May 24, 2023Medical Communications FDA, Infections and infestations, Innoviva, pneumonia
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, has announced that the US Food and Drug Administration (FDA) has approved Xacduro …
Top Ten most popular articles on Pharmafile.com this week!
May 10, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, GSK, Innoviva, NHS, Novartis, health, migraine, pharma
This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving …
GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3
May 3, 2019Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma
GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …
GSK 18 months ahead of the game with three-drug inhaler
November 21, 2016Medical Communications, Sales and Marketing GSK, Innoviva, chronic obstructive pulmonary disease
GlaxoSmithKline, alongside its partner Innoviva, have filed a regulatory submission with the FDA for its treatment for chronic obstructive pulmonary …
GSK announce positive results for chronic obstructive pulmonary disease treatment
September 5, 2016Manufacturing and Production, Research and Development, Sales and Marketing GlaxoSmithKline, Innoviva, Revlar Ellipta, chronic obstructive pulmonary disease
GlaxoSmithKline and its partner Innoviva have announced that its Relvar Ellipta achieved positive results in its COPD Salford lung study …
